ArticlePharmaceuticals (Basel, Switzerland)2022
Chitosan/Cyclodextrin Nanospheres for Potential Nose-to-Brain Targeting of Idebenone.
Federica De Gaetano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papertrialcites it